SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-013423
Filing Date
2021-10-25
Accepted
2021-10-25 07:40:40
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20210930x10q.htm   iXBRL 10-Q 2203256
2 EX-10.1 qure-20210930xex10d1.htm EX-10.1 90442
3 EX-31.1 qure-20210930xex31d1.htm EX-31.1 15330
4 EX-31.2 qure-20210930xex31d2.htm EX-31.2 15322
5 EX-32.1 qure-20210930xex32d1.htm EX-32.1 15066
  Complete submission text file 0001558370-21-013423.txt   7909999

Data Files

Seq Description Document Type Size
6 EX-101.SCH qure-20210930.xsd EX-101.SCH 49872
7 EX-101.CAL qure-20210930_cal.xml EX-101.CAL 43618
8 EX-101.DEF qure-20210930_def.xml EX-101.DEF 257085
9 EX-101.LAB qure-20210930_lab.xml EX-101.LAB 503691
10 EX-101.PRE qure-20210930_pre.xml EX-101.PRE 401657
11 EXTRACTED XBRL INSTANCE DOCUMENT qure-20210930x10q_htm.xml XML 1250558
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 211342157
SIC: 2834 Pharmaceutical Preparations